- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- NAG- MAN: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- FUC: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-FUC.3: 3 residues within 4Å:- Chain A: N.194, T.196, Y.206
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:T.196
NAG-NAG-BMA-MAN-FUC.7: 3 residues within 4Å:- Chain D: N.194, T.196, Y.206
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:T.196
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 10 x CLR: CHOLESTEROL(Non-covalent)
CLR.9: 6 residues within 4Å:- Chain A: C.46, G.49, I.50, G.53, Q.56
- Ligands: PCW.33
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.50, A:Q.56
CLR.10: 6 residues within 4Å:- Chain A: R.28, W.33, Y.40, Y.44
- Chain B: E.852
- Ligands: PCW.16
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:W.33, A:Y.40, A:Y.40
- Hydrogen bonds: A:R.28
CLR.11: 12 residues within 4Å:- Chain B: W.936, T.967, Y.975, P.990, W.993, F.997
- Chain C: L.39, V.42, V.46
- Ligands: PCW.13, PCW.14, PCW.27
8 PLIP interactions:7 interactions with chain B, 1 interactions with chain C- Hydrophobic interactions: B:T.967, B:Y.975, B:P.990, B:W.993, B:W.993, B:W.993, B:F.997, C:V.46
CLR.12: 11 residues within 4Å:- Chain A: V.57, T.61, K.68
- Chain B: F.872, E.880, S.991
- Chain E: L.1005
- Ligands: PCW.28, CLR.32, PCW.33, PCW.35
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:V.57, A:T.61, B:F.872
- Hydrogen bonds: A:K.68, A:K.68
CLR.18: 5 residues within 4Å:- Chain B: I.111, L.115, L.323, I.330
- Ligands: 01.25
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:I.111, B:L.115, B:I.330
CLR.29: 6 residues within 4Å:- Chain D: C.46, G.49, I.50, G.53, Q.56
- Ligands: PCW.28
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:I.50, D:Q.56
CLR.30: 6 residues within 4Å:- Chain D: R.28, W.33, Y.40, Y.44
- Chain E: E.852
- Ligands: PCW.37
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:W.33, D:Y.40, D:Y.40
- Hydrogen bonds: D:R.28
CLR.31: 12 residues within 4Å:- Chain E: W.936, T.967, Y.975, P.990, W.993, F.997
- Chain F: L.39, V.42, V.46
- Ligands: PCW.34, PCW.35, PCW.48
8 PLIP interactions:7 interactions with chain E, 1 interactions with chain F- Hydrophobic interactions: E:T.967, E:Y.975, E:P.990, E:W.993, E:W.993, E:W.993, E:F.997, F:V.46
CLR.32: 11 residues within 4Å:- Chain B: L.1005
- Chain D: V.57, T.61, K.68
- Chain E: F.872, E.880, S.991
- Ligands: CLR.12, PCW.14, PCW.28, PCW.33
5 PLIP interactions:4 interactions with chain D, 1 interactions with chain E- Hydrophobic interactions: D:V.57, D:T.61, E:F.872
- Hydrogen bonds: D:K.68, D:K.68
CLR.39: 5 residues within 4Å:- Chain E: I.111, L.115, L.323, I.330
- Ligands: 01.46
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:I.111, E:L.115, E:I.330
- 16 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PCW.13: 15 residues within 4Å:- Chain B: W.936, I.949, Q.952, G.953, M.954, K.955, L.963, T.967, F.997, S.1000
- Chain C: L.50
- Ligands: CLR.11, PCW.14, PCW.27, PCW.35
Ligand excluded by PLIPPCW.14: 14 residues within 4Å:- Chain B: F.950, Q.951, L.1001, F.1004, L.1005, F.1012
- Chain E: F.994, L.1001
- Ligands: CLR.11, PCW.13, PCW.27, CLR.32, PCW.34, PCW.35
Ligand excluded by PLIPPCW.15: 8 residues within 4Å:- Chain B: L.969, F.972, C.976, P.977, G.978, V.981, A.982
- Ligands: PCW.26
Ligand excluded by PLIPPCW.16: 13 residues within 4Å:- Chain A: Y.44, F.51, I.52, I.55, L.59
- Chain B: T.793, M.864, F.871, F.875, P.885, M.886, I.889
- Ligands: CLR.10
Ligand excluded by PLIPPCW.17: 5 residues within 4Å:- Chain B: I.299, T.846, E.852, R.853, I.855
Ligand excluded by PLIPPCW.26: 9 residues within 4Å:- Chain B: P.977
- Chain C: Y.36, Y.37, R.40, V.41, L.44, I.45, V.52
- Ligands: PCW.15
Ligand excluded by PLIPPCW.27: 8 residues within 4Å:- Chain B: F.964, P.990
- Chain C: Y.34, V.42, L.50
- Ligands: CLR.11, PCW.13, PCW.14
Ligand excluded by PLIPPCW.28: 13 residues within 4Å:- Chain A: K.35
- Chain B: L.1001, I.1002, L.1005, Y.1006, M.1009, G.1020
- Chain D: I.50, V.57
- Ligands: CLR.12, CLR.29, CLR.32, PCW.33
Ligand excluded by PLIPPCW.33: 13 residues within 4Å:- Chain A: I.50, V.57
- Chain D: K.35
- Chain E: L.1001, I.1002, L.1005, Y.1006, M.1009, G.1020
- Ligands: CLR.9, CLR.12, PCW.28, CLR.32
Ligand excluded by PLIPPCW.34: 15 residues within 4Å:- Chain E: W.936, I.949, Q.952, G.953, M.954, K.955, L.963, T.967, F.997, S.1000
- Chain F: L.50
- Ligands: PCW.14, CLR.31, PCW.35, PCW.48
Ligand excluded by PLIPPCW.35: 14 residues within 4Å:- Chain B: F.994, L.1001
- Chain E: F.950, Q.951, L.1001, F.1004, L.1005, F.1012
- Ligands: CLR.12, PCW.13, PCW.14, CLR.31, PCW.34, PCW.48
Ligand excluded by PLIPPCW.36: 8 residues within 4Å:- Chain E: L.969, F.972, C.976, P.977, G.978, V.981, A.982
- Ligands: PCW.47
Ligand excluded by PLIPPCW.37: 13 residues within 4Å:- Chain D: Y.44, F.51, I.52, I.55, L.59
- Chain E: T.793, M.864, F.871, F.875, P.885, M.886, I.889
- Ligands: CLR.30
Ligand excluded by PLIPPCW.38: 5 residues within 4Å:- Chain E: I.299, T.846, E.852, R.853, I.855
Ligand excluded by PLIPPCW.47: 9 residues within 4Å:- Chain E: P.977
- Chain F: Y.36, Y.37, R.40, V.41, L.44, I.45, V.52
- Ligands: PCW.36
Ligand excluded by PLIPPCW.48: 8 residues within 4Å:- Chain E: F.964, P.990
- Chain F: Y.34, V.42, L.50
- Ligands: CLR.31, PCW.34, PCW.35
Ligand excluded by PLIP- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.20: 17 residues within 4Å:- Chain B: K.382, T.383, D.455, S.457, E.458, F.487, S.489, K.492, Q.494, K.513, R.556, L.558, T.622, G.623, D.624, R.697
- Ligands: MG.19
14 PLIP interactions:14 interactions with chain B- Hydrogen bonds: B:K.382, B:T.383, B:T.383, B:S.457, B:S.489, B:Q.494, B:Q.494, B:R.556, B:G.623, B:D.624
- Salt bridges: B:K.492, B:R.556
- pi-Stacking: B:F.487, B:F.487
ATP.41: 17 residues within 4Å:- Chain E: K.382, T.383, D.455, S.457, E.458, F.487, S.489, K.492, Q.494, K.513, R.556, L.558, T.622, G.623, D.624, R.697
- Ligands: MG.40
14 PLIP interactions:14 interactions with chain E- Hydrogen bonds: E:K.382, E:T.383, E:T.383, E:S.457, E:S.489, E:Q.494, E:Q.494, E:R.556, E:G.623, E:D.624
- Salt bridges: E:K.492, E:R.556
- pi-Stacking: E:F.487, E:F.487
- 8 x NA: SODIUM ION(Non-functional Binders)
NA.21: 0 residues within 4Å:- (No contacts)
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.339
NA.22: 4 residues within 4Å:- Chain B: T.784, S.787, N.788, D.820
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.816
NA.23: 4 residues within 4Å:- Chain B: Y.783, T.786, Q.935, D.938
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:Y.783, B:S.787, B:Q.935, B:D.938
NA.24: 3 residues within 4Å:- Chain B: K.731, A.733, D.752
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:K.731
NA.42: 0 residues within 4Å:- (No contacts)
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:E.339
NA.43: 4 residues within 4Å:- Chain E: T.784, S.787, N.788, D.820
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:T.784
NA.44: 4 residues within 4Å:- Chain E: Y.783, T.786, Q.935, D.938
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:S.787, E:Q.935, E:Q.935, E:D.938
NA.45: 3 residues within 4Å:- Chain E: K.731, A.733, D.752
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:D.752
- 2 x 01: palytoxin
01.25: 25 residues within 4Å:- Chain B: L.115, A.119, I.122, L.316, I.317, G.319, Y.320, W.322, L.323, E.324, I.327, F.328, G.331, V.334, A.335, V.337, E.339, E.791, I.792, F.795, L.805, T.809, I.812, D.816
- Ligands: CLR.18
15 PLIP interactions:15 interactions with chain B- Hydrophobic interactions: B:L.115, B:I.122, B:L.316, B:W.322, B:F.328, B:A.335, B:I.792, B:F.795, B:F.795, B:L.805
- Hydrogen bonds: B:L.316, B:I.317, B:V.337, B:T.809, B:T.809
01.46: 25 residues within 4Å:- Chain E: L.115, A.119, I.122, L.316, I.317, G.319, Y.320, W.322, L.323, E.324, I.327, F.328, G.331, V.334, A.335, V.337, E.339, E.791, I.792, F.795, L.805, T.809, I.812, D.816
- Ligands: CLR.39
15 PLIP interactions:15 interactions with chain E- Hydrophobic interactions: E:L.115, E:I.122, E:L.316, E:W.322, E:F.328, E:A.335, E:I.792, E:F.795, E:F.795, E:L.805
- Hydrogen bonds: E:L.316, E:I.317, E:V.337, E:T.809, E:T.809
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kanai, R. et al., How palytoxin transforms the Na + ,K + pump into a cation channel. Proc.Natl.Acad.Sci.USA (2025)
- Release Date
- 2025-10-01
- Peptides
- Na+,K+-ATPase beta subunit: AD
Na, K-ATPase alpha subunit: BE
FXYD domain-containing ion transport regulator: CF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DD
BB
CE
AC
EF
G - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- NAG- MAN: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- FUC: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 10 x CLR: CHOLESTEROL(Non-covalent)
- 16 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x NA: SODIUM ION(Non-functional Binders)
- 2 x 01: palytoxin
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kanai, R. et al., How palytoxin transforms the Na + ,K + pump into a cation channel. Proc.Natl.Acad.Sci.USA (2025)
- Release Date
- 2025-10-01
- Peptides
- Na+,K+-ATPase beta subunit: AD
Na, K-ATPase alpha subunit: BE
FXYD domain-containing ion transport regulator: CF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DD
BB
CE
AC
EF
G - Membrane
-
We predict this structure to be a membrane protein.